Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B Versus Posaconazole for Treating Pulmonary Mucormycosis
NCT05468372Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in mucormycosis, sponsored by Post Graduate Institute of Medical Education and Research. Started Jul 2022; status: completed.
02
Drugs
posaconazole
03
Conditions
mucormycosis
Beyond the preview
Go deeper on NCT05468372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468372.